Twist Bioscience (TWST) Free Cash Flow (2017 - 2026)

Twist Bioscience (TWST) has 10 years of Free Cash Flow data on file, last reported at -$13.1 million in Q1 2026.

• Free Cash Flow for Q1 2026 came in at -$13.1 million, down 7.77% year-over-year; the trailing twelve-month figure through Mar 2026 was -$87.8 million (down 45.35% YoY), and the FY2025 annual result was -$75.6 million, down 9.34% from the prior year.
• Free Cash Flow grew to -$13.1 million in Q1 2026 per TWST's latest filing, from -$34.8 million in the prior quarter.
• Over five years, Free Cash Flow peaked at $3.9 million in Q3 2023 and troughed at -$74.8 million in Q2 2022.
• A 5-year average of -$29.6 million and a median of -$23.6 million in 2024 frame the typical range for Free Cash Flow.
• The sharpest annual moves came in 2023 and 2024: Free Cash Flow soared 122.05% in 2023, then plunged 543.02% in 2024.
• A 5-year view of Free Cash Flow shows it stood at -$65.9 million in 2022, then jumped by 62.85% to -$24.5 million in 2023, then advanced by 3.74% to -$23.6 million in 2024, then slumped by 47.63% to -$34.8 million in 2025, then jumped by 62.27% to -$13.1 million in 2026.
• Business Quant data shows TWST's Free Cash Flow at -$13.1 million in Q1 2026, -$34.8 million in Q4 2025, and -$24.2 million in Q3 2025.